STUDY OBJECTIVES: To determine cardiac structural abnormalities by echocardiography in subjects with severe obstructive sleep apnea (OSA), and to determine the long-term effects of nasal continuous positive airway pressure (CPAP) on such abnormalities. DESIGN: Polysomnography was conducted on oximetry-screened patients who showed a desaturation index > 40/h and > or = 20% cumulative time spent below 90%. From these, 25 patients with severe OSA but without daytime hypoxemia underwent echocardiography prior to, then 1 month and 6 months following initiation of CPAP treatment. SETTING: Outpatient sleep disorders center. RESULTS: Of the 25 patients, 13 patients (52%) had hypertension by history or on physical examination. Baseline echocardiograms showed that severe OSA was associated with numerous cardiovascular abnormalities, including left ventricular hypertrophy (LVH) [88%], left atrial enlargement (LAE) [64%], right atrial enlargement (RAE) [48%], and right ventricular hypertrophy (16%). In all patients (intent to treat) as well as those patients compliant with CPAP therapy (84% > 3 h nightly), there was a significant reduction in LVH after 6 months of CPAP therapy as measured by interventricular septal distance (baseline diastolic mean, 13.0 mm; 6-month mean after CPAP, 12.3 mm; p < 0.02). RAE and LAE were unchanged after CPAP therapy. CONCLUSIONS: LVH was present in high frequency in subjects with severe OSA and regressed after 6 months of nasal CPAP therapy.
STUDY OBJECTIVES: To determine cardiac structural abnormalities by echocardiography in subjects with severe obstructive sleep apnea (OSA), and to determine the long-term effects of nasal continuous positive airway pressure (CPAP) on such abnormalities. DESIGN: Polysomnography was conducted on oximetry-screened patients who showed a desaturation index > 40/h and > or = 20% cumulative time spent below 90%. From these, 25 patients with severe OSA but without daytime hypoxemia underwent echocardiography prior to, then 1 month and 6 months following initiation of CPAP treatment. SETTING:Outpatientsleep disorders center. RESULTS: Of the 25 patients, 13 patients (52%) had hypertension by history or on physical examination. Baseline echocardiograms showed that severe OSA was associated with numerous cardiovascular abnormalities, including left ventricular hypertrophy (LVH) [88%], left atrial enlargement (LAE) [64%], right atrial enlargement (RAE) [48%], and right ventricular hypertrophy (16%). In all patients (intent to treat) as well as those patients compliant with CPAP therapy (84% > 3 h nightly), there was a significant reduction in LVH after 6 months of CPAP therapy as measured by interventricular septal distance (baseline diastolic mean, 13.0 mm; 6-month mean after CPAP, 12.3 mm; p < 0.02). RAE and LAE were unchanged after CPAP therapy. CONCLUSIONS: LVH was present in high frequency in subjects with severe OSA and regressed after 6 months of nasal CPAP therapy.
Authors: Partho P Sengupta; Dan Sorajja; Mackram F Eleid; Virend K Somers; Steve R Ommen; James M Parish; Bijoy Khandheria; A Jamil Tajik Journal: Nat Clin Pract Cardiovasc Med Date: 2008-11-18
Authors: Himad K Khattak; Faisal Hayat; Salpy V Pamboukian; Harvey S Hahn; Brian P Schwartz; Phyllis K Stein Journal: Tex Heart Inst J Date: 2018-06-01
Authors: Hassan A Chami; Richard B Devereux; John S Gottdiener; Reena Mehra; Mary J Roman; Emelia J Benjamin; Daniel J Gottlieb Journal: Circulation Date: 2008-05-05 Impact factor: 29.690
Authors: Chris B Johnson; Rob S Beanlands; Keiichiro Yoshinaga; Haissam Haddad; Judith Leech; Rob de Kemp; Ian G Burwash Journal: Can J Cardiol Date: 2008-09 Impact factor: 5.223
Authors: Pedro Pujante; Cristina Abreu; Jose Moreno; Eduardo Alegria Barrero; Pedro Azcarate; Arantxa Campo; Elena Urrestarazu; Camilo Silva; Jesus Gil Maria; Javier Tebar; Gema Frühbeck; Javier Salvador Journal: J Clin Sleep Med Date: 2013-11-15 Impact factor: 4.062
Authors: Christoforos D Giannaki; Paris Zigoulis; Christina Karatzaferi; Georgios M Hadjigeorgiou; Keith P George; Konstantinos Gourgoulianis; Yiannis Koutedakis; Ioannis Stefanidis; Giorgos K Sakkas Journal: J Clin Sleep Med Date: 2013-02-01 Impact factor: 4.062